Kazuhiro Tateda Selected Research

Kazuhiro Tateda Research Topics

Disease

50	Infections 12/2022 - 10/2000
36	Pneumonia (Pneumonitis) 07/2021 - 11/2000
18	Communicable Diseases (Infectious Diseases) 08/2023 - 06/2005
11	COVID-19 06/2023 - 12/2020
8	Necrosis 04/2021 - 10/2000
7	Sepsis (Septicemia) 01/2020 - 06/2005
5	Clostridium Infections 03/2024 - 08/2016
4	Pneumococcal Pneumonia 10/2016 - 08/2003
4	Hyperoxia 10/2013 - 04/2003
3	Septic Shock (Toxic Shock Syndrome) 02/2024 - 05/2019
3	Surgical Wound Infection 11/2023 - 01/2020
3	Respiratory Tract Infections (Respiratory Tract Infection) 08/2023 - 01/2008
3	Pseudomembranous Enterocolitis (Pseudomembranous Colitis) 04/2021 - 02/2010
3	Acute Lung Injury 11/2010 - 04/2003
2	Bacteremia 12/2023 - 09/2009
2	Mycoses (Diseases, Fungus) 02/2023 - 08/2018
2	Pulmonary Aspergillosis 02/2023 - 01/2017
2	Legionellosis 02/2022 - 02/2010
2	Colitis 01/2020 - 01/2019
2	Cough 06/2019 - 11/2017
2	Inflammation (Inflammations) 01/2019 - 12/2004
2	Shock 12/2017 - 08/2013
2	Fever (Fevers) 11/2017 - 10/2002
2	Cross Infection (Nosocomial Infection) 11/2017 - 08/2017
2	Pneumococcal Infections 01/2013 - 01/2008
2	Legionnaires' Disease (Legionnaire's Disease) 04/2006 - 06/2002
1	Chromosome Inversion (Chromosomal Inversion) 02/2024
1	Cellulitis 12/2023
1	Multiple Myeloma 12/2023
1	Aspergillosis 02/2023
1	Mucormycosis 02/2023
1	Drug-Related Side Effects and Adverse Reactions 02/2023
1	Cryptococcosis 02/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023

Drug/Important Bio-Agent (IBA)

14	Anti-Bacterial Agents (Antibiotics)IBA 04/2021 - 12/2007
14	AntigensIBA 02/2021 - 06/2002
11	CytokinesIBA 05/2019 - 10/2000
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2009 - 10/2000
6	Vancomycin FDA LinkGeneric 03/2024 - 01/2019
6	Anti-Infective Agents (Microbicides)IBA 08/2023 - 07/2011
5	Interleukin-6 (Interleukin 6)IBA 12/2017 - 10/2000
5	MacrolidesIBA 10/2016 - 12/2007
5	Azithromycin (Zithromax)FDA LinkGeneric 10/2016 - 12/2004
4	Carbapenems (Carbapenem Antibiotics)IBA 10/2021 - 04/2014
4	FidaxomicinIBA 07/2020 - 09/2018
4	Interleukin-17 (Interleukin 17)IBA 01/2020 - 03/2012
4	FluoroquinolonesIBA 01/2020 - 12/2004
4	C-Reactive ProteinIBA 06/2019 - 01/2008
4	InterleukinsIBA 01/2019 - 11/2001
3	Immunoglobulin G (IgG)IBA 11/2021 - 09/2021
3	Indicators and Reagents (Reagents)IBA 02/2021 - 01/2005
3	Colistin (Coly-Mycin)FDA Link 12/2017 - 03/2009
3	Imipenem FDA Link 09/2017 - 01/2013
3	Virulence Factors (Pathogenicity Factors)IBA 08/2017 - 10/2003
3	LipopolysaccharidesIBA 08/2013 - 10/2000
3	Capsules (Microcapsules)IBA 06/2011 - 11/2000
3	Interleukin-1 (Interleukin 1)IBA 09/2009 - 01/2005
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2009 - 08/2001
2	PowdersIBA 11/2023 - 01/2020
2	EnzymesIBA 06/2021 - 01/2013
2	Linezolid (Zyvox)FDA Link 02/2020 - 04/2012
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2019 - 11/2017
2	Panton-Valentine leukocidinIBA 01/2018 - 07/2015
2	InterferonsIBA 01/2018 - 11/2001
2	Clarithromycin (Biaxin)FDA LinkGeneric 11/2017 - 02/2010
2	Interleukin-10 (Interleukin 10)IBA 02/2017 - 05/2001
2	polyglucosanIBA 01/2017 - 01/2008
2	SteroidsIBA 07/2015 - 01/2015
2	CalciumIBA 10/2013 - 11/2010
2	AntioxidantsIBA 10/2013 - 08/2004
2	Edetic Acid (EDTA)FDA Link 10/2013 - 11/2010
2	AcidsIBA 10/2013 - 02/2010
2	EndotoxinsIBA 08/2013 - 06/2010
2	EDP 420IBA 07/2011 - 04/2011
2	Methotrexate (Mexate)FDA LinkGeneric 01/2011 - 01/2008
2	DNA (Deoxyribonucleic Acid)IBA 03/2010 - 04/2003
2	Ciprofloxacin (Cipro)FDA LinkGeneric 02/2010 - 12/2004
2	Erythromycin (Erycette)FDA LinkGeneric 12/2007 - 01/2004
2	Oxygen (Dioxygen)IBA 08/2004 - 04/2003
2	Interferon-gamma (Interferon, gamma)IBA 11/2001 - 05/2001
2	factor AIBA 05/2001 - 11/2000
1	Metronidazole (Metric)FDA LinkGeneric 03/2024
1	Leukocidins (Leukocidin)IBA 02/2024
1	Staphylococcal enterotoxin FIBA 02/2024
1	immunoglobulin BIBA 06/2023
1	isavuconazoleIBA 02/2023
1	Voriconazole (Vfend)FDA LinkGeneric 02/2023
1	Meropenem (Merrem)FDA LinkGeneric 12/2022
1	VaccinesIBA 12/2022
1	Antiviral Agents (Antivirals)IBA 12/2022
1	Viral RNAIBA 09/2022
1	Uric Acid (Urate)IBA 04/2022
1	favipiravirIBA 04/2022
1	Nucleic AcidsIBA 02/2022
1	homocysteine-thiolactone-nicotinamide (ST 22)IBA 01/2022
1	AntibodiesIBA 09/2021

Therapy/Procedure

15	Therapeutics 01/2023 - 08/2004
11	Drug Therapy (Chemotherapy) 12/2023 - 12/2007
2	Aftercare (After-Treatment) 07/2021 - 01/2004
2	Oral Administration 03/2014 - 02/2007